Clare Taylor

Active 1986–2025

79
Papers
17,995
Citations
46
h-index
70
i10-index

Citations

Citations per year for Clare Taylor1972: 1 citations1990: 1 citations1992: 2 citations1993: 3 citations1994: 8 citations1995: 9 citations1996: 7 citations1997: 10 citations1998: 12 citations1999: 14 citations2000: 12 citations2001: 13 citations2002: 15 citations2003: 21 citations2004: 29 citations2005: 27 citations2006: 21 citations2007: 28 citations2008: 34 citations2009: 29 citations2010: 41 citations2011: 33 citations2012: 55 citations2013: 133 citations2014: 128 citations2015: 156 citations2016: 164 citations2017: 295 citations2018: 313 citations2019: 885 citations2020: 929 citations2021: 653 citations2022: 406 citations2023: 296 citations2024: 467 citations2025: 204 citations2026: 14 citations1973–1989: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,096 citing papers, 20.1% of this breakdownUnited Kingdom: 1,024 citing papers, 9.8% of this breakdownGermany: 726 citing papers, 7% of this breakdownChina: 622 citing papers, 6% of this breakdownItaly: 524 citing papers, 5% of this breakdownNetherlands: 446 citing papers, 4.3% of this breakdownCanada: 384 citing papers, 3.7% of this breakdownFrance: 377 citing papers, 3.6% of this breakdownSpain: 352 citing papers, 3.4% of this breakdownAustralia: 336 citing papers, 3.2% of this breakdownDenmark: 334 citing papers, 3.2% of this breakdownSweden: 240 citing papers, 2.3% of this breakdown
0%20.1%Other 28.4%

Fields

  • Medicine84.2%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Immunology and Microbiology2.2%
  • Neuroscience2.1%
  • Psychology1.6%
  • Environmental Science1%
  • Other3.1%

Topics

  • Atrial Fibrillation Management and Outcomes10.6%
  • CAR-T cell therapy research8.4%
  • Cardiac Arrhythmias and Treatments4.3%
  • Virus-based gene therapy research2.6%
  • Immune Cell Function and Interaction2.5%
  • Cardiovascular Function and Risk Factors2.2%
  • Other69.4%

Coauthors

All papers

Open in search
  1. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2013 cited by 2,077

  2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bülent Görenek, Maxine Guenoun, Stefan H. Hohnloser, Philippe Kolh, Gregory Y.H. Lip, Athanasios Manolis, John J.V. McMurray, Piotr Ponikowski, Raphaël Rosenhek, Frank Ruschitzka, Irina Savelieva, Sanjay Sharma, Piotr Suwalski, Juan Tamargo, Clare Taylor, Isabelle C. Van Gelder, Adriaan A. Voors, Stephan Windecker, José Luis Zamorano, Katja Zeppenfeld - EP Europace 2016 cited by 6,477

  3. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , А. О. Недошивин, A-S Petronio, Jolien W. Roos‐Hesselink, Lars Wallentin, Uwe Zeymer, Gilbert Habib, Patrizio Lancellotti, B Cosyns, Erwan Donal, Paola Anna Erba, Bernard Iung, Aldo P. Maggioni, Bogdan A. Popescu, B Prendergast, P. Tornos, Maryna Andarala, C Berle, A Brunel-Lebecq, E Fiorucci, C Laroche, V. Missiamenou, Clare Taylor, Nora Nabila Ali Tatar-Chentir, Mouaz H. Al‐Mallah, Meriam Åström Aneq, George Athanassopoulos, Luigi P. Badano, S. Benyoussef, Erick Calderón-Aranda, Nuno Cardim, KL Chan, B Cosyns, Isabel Cruz, Thor Edvardsen, Georg Goliasch, Gilbert Habib, Andreas Hagendorff, Krasimira Hristová, Bernard Iung, Otto Kamp, D-H Kang, William Kong, С.Т. Мацкеплишвили, Marwa Meshaal, M Mirocevic, Aleksandar Nešković, Michal Pazderník, E Plonska-Gosciniak, Bogdan A. Popescu, B Prendergast, Maha Raissouni, Ricardo Ronderos, L E Sade, Anita Sadeghpour, Antonia Sambola, Shantanu P. Sengupta, J Separovic-Hanzevacki, Masami Takeuchi, Edwin S. Tucay, Ana Clara Tude Rodrigues, Andréa Varga, J. Vaskelyte, Kazufumi Yamagata, K Yiangou, H Zaky, Isabel Granada, M Mahia, S Ressi, Francisco Nacinovich, Ana Iribarren and 853 more - European Heart Journal 2019 cited by 867

  4. Survival of Patients with Chronic Heart Failure in the Community: A Systematic Review and Meta-Analysis

    Authors: , , , , - European Journal of Heart Failure 2019 cited by 604

  5. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 1,284

  6. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study

    Authors: , , , , , , - BMJ 2019 cited by 498

  7. Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martyn Snow, Marion Campbell, Tessa Howell, Hilary Johnson, Stephen McDonnell, Thomas Pinkney, Mark R. Williams, Helen Campbell, Jackie Davies, Jiyang Li, C. Bagg, Laura Haywood, Anne Nicholson, Joanne Riches, Sean Symons, Mark Vertue, Louay Al Mouazzen, Rachel Bray, Damian Clark, James Coulthard, T. J. B. Holland, Nick Howells, Andrew K. Jones, Richard Kapur, Alastair Kiszely, Harry Krishnan, Karen MacDonald-Taylor, Jon Manara, James L. Murray, Corina Negrut, Vishai Pai, Andrew Porteous, Sven Putnis, James L. Robinson, Shav Rupasinghe, Veenesh Selvaratnam, James Q. Smith, Nick Smith, Jarrad Stevens, Clare Taylor, Anthony Theodorides, Niraj Vetharajan, Helen Vint, Lucy H. Young, S Bullock, Rebecca Cook, Alexander L. Dodds, Amanda Freeman-Hicks, Paula Hillout, Thomas Cornell, Abbie Coutts, Suzy Dean, Nicki Devooght-Johnson, Emma Ferrell, Eve Fletcher, Chrissie Hall, Benjamin Kent, Sandra Kessly, Robin Kincaid, Mohamed Lazizi, Ahmed Mostafa, Toby Nisbett, Timothy J. Powell, P Riddlestone, Andrew Roberton, Jessica J. Summers, Lucy Whitbread, Belinda Wroath, Emma Fenlon, Andrew Hall and 241 more - The Lancet 2022 cited by 135

  8. Towards estimating the carbon footprint of external beam radiotherapy

    Authors: , , , , , , , , , , , , - Physica Medica 2023 cited by 50

  9. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study

    Authors: , , , , , , , , , , , - British Journal of General Practice 2020 cited by 80

  10. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

    Authors: , , , , , , , , , - The Lancet 2002 cited by 365

  11. Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy

    Authors: , , , , , , , , , , , , - Journal of Immunotherapy 2009 cited by 319

  12. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2018 cited by 118

  13. Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke—Blood Pressure) randomised controlled trial

    Authors: , , , , , , , , - BMJ 2016 cited by 89

  14. Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , BARACK-D Investigators, J. Townend, C. Ferro, P. Bower, A. Farmer, D. Fitzmaurice, G. Feder, P. Little, N. Qureshi, Oxford, F. D. Richard Hobbs, R. Perera, D. Timmins, Birmingham, D. Fitzmaurice, G. Heer, R. Della, H. Duffy, F. McRonald, D. Popoola, K. Jheeta, Bristol, G. Feder, S. Bryant, Derby, M. Taal, Y. Newey, D. Morgan, Manchester, P. Bower, C. Gardner, V. Lee, T. Blakeman, Nottingham, N. Qureshi, L. Cross-Bardell, C. Brindley, Southampton, P. Little, J. Barnett, K. Middleton - Nature Medicine 2024 cited by 46

  15. Functional, biochemical and genetic diversity of prokaryotic nitrate reductases

    Authors: , , , , - Cellular and Molecular Life Sciences 2001 cited by 471

  16. Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review

    Authors: , , , , , - PLoS ONE 2021 cited by 60

  17. Body mass index and survival in people with heart failure

    Authors: , , , , , , - Heart 2023 cited by 46

  18. Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy

    Authors: , , , , , , , , , , - Clinical Cancer Research 2007 cited by 214

  19. National trends in heart failure mortality in men and women, United Kingdom , 2000–2017

    Authors: , , , , , , - European Journal of Heart Failure 2020 cited by 59

  20. Screening for atrial fibrillation: a call for evidence

    Authors: , , , , - European Heart Journal 2019 cited by 182

  21. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor–Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching

    Authors: , , , , , - American Journal of Transplantation 2016 cited by 121

  22. Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018

    Authors: , , , , , , - Heart 2021 cited by 30

  23. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Oncotarget 2011 cited by 170

  24. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Trevor Cole, Sheila Seal, Nazneen Rahman - American Journal of Medical Genetics Part A 2013 cited by 149